Drug Development Unit

Sarah Cannon Research Institute at Florida Cancer Specialists

Phase I Clinical Trials

As a strategic research site for Sarah Cannon Research Institute, one of the leading clinical trial organizations in the world, Florida Cancer Specialists (FCS) conducts clinical trials research at more than 30 locations throughout the state, including at our Drug Development Unit (DDU) in Sarasota, which is dedicated exclusively to Phase I Clinical Trials. Rivaling many larger academic medical centers, FCS is one of only a handful of community practices in the nation to offer this level of clinical research.

Since the DDU was established in 2011, the Phase 1 Trials program at FCS has grown exponentially to become one of the leading clinical research programs in the nation.

In 2016, 230 new patients were enrolled in over 40 Phase I trials, rivaling most academic centers

Page Divider

Drug Development Unit - Principal InvestigatorsĀ 

Manish  R. Patel, MD

Manish R. Patel, MD

View Profile
Judy   Wang, MD

Judy Wang, MD

View Profile